Till Winfried Bärnighausen
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Till Winfried Bärnighausen (born 1969) is an Alexander von Humboldt University Professor and Director of the Heidelberg Institute of Global Health at the Faculty of Medicine, University of Heidelberg, Germany. He is also Adjunct Professor of Global Health at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health, a Faculty Member at the Harvard Center for Population and Development Studies, and a Senior Faculty at the Wellcome Trust's Africa Health Research Institute in South Africa.
Biography[edit]
Until 1997, Bärnighausen studied medicine at the Ruprecht-Karls-Universität Heidelberg. In 1998, he finished his doctoral degree (in the field of medical history focusing on experiments on human beings by the Japanese military in China during the second world war).[1] His higher specialist training focused on internal medicine (Zulassung 2002). In 2001, he finished his master's degree in Health System Management at the London School of Hygiene and Tropical Medicine and in 2006 he finished his master's degree in Master-Abschluss in Economics and Finance at the London University. From 2004 onwards, he became associate professor at the Africa Health Research Institute (AHRI) of the Wellcome Trust at the University of KwaZulu-Natal in South Africa. In 2008, he finished acquired the Doctor of Science (Sc.D. in Population and International Health) at T.H. Chan School of Public Health, where he was appointed professor in 2009. In 2016, he moved back to Heidelberg University where he received an Alexander von Humboldt-professorship leading the Heidelberg Institute of Global Health (HIGH).
Bärnighausen's research focuses on establishing the causal impact of global health interventions on population health, social, and economic outcomes. In particular, he works on large-scale population health interventions for HIV, diabetes , hypertension, and vaccine-preventable diseases. His research has been funded by the Alexander von Humboldt Foundation, the Wellcome Trust, NIH (including 6 R01 grants), the European Union, ANRS, International Initiative for Impact Evaluation (3ie), the Clinton Health Access Initiative (CHAI), the Elton John AIDS Foundation, the Rush Foundation, USAID, UNAIDS, World Bank, and GAVI. In 2016, Till Bärnighausen received the Alexander von Humboldt Professor Award, Germany's most highly endowed international science price.
References[edit]
- ^ Bärnighausen, Medizinische Humanexperimente der japanischen Truppen für biologische Kriegsführung in China, 1932–1945. Dissertation, Heidelberg 1998. Frankfurt: Lang 2002
External links[edit]
- Till Bärnighausen Profile at Heidelberg University, Heidelberg Institute of Global Health
- Humboldt Professor Till Bärnighausen, Heidelberg University, 17 May 2017
- Webseite Harvard T.H. Chan of Public Health, Department of Global Health and Population
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
- 1969 births
- Living people
- Heidelberg University alumni
- Academic staff of Heidelberg University
- 20th-century German physicians
- 21st-century German physicians
- Alumni of the London School of Hygiene and Tropical Medicine
- Harvard Medical School faculty
- Academic staff of the University of KwaZulu-Natal
- German expatriates in South Africa
- German expatriates in the United States
- German expatriates in the United Kingdom
- Harvard T.H. Chan School of Public Health alumni